Antimicrobial Potential of Extract from a Pseudomonas aeruginosa Isolate

Table 2

Antimicrobial activity of isolate DO5 using the agar well diffusion method.

Isolates	Test microorganisms/Mean zones of inhibition (mm)
	ST	CA	EF	EC	PA	KP	SA	SP	PM	VC
DO1	—	—	—	—	15.50 ± 0.707	—	—	—	17.50 ± 0.707	—
DO2	—	16.50 ± 0.707	—	—	—	—	—	—	13.50 ± 0.707	—
DO5	15.0 ± 1.414	17.50 ± 0.707	19.50 ± 0.707	21.50 ± 0.707	16.0 ± 1.414	19.50 ± 0.707	19.50 ± 1.414	16.50 ± 1.414	15.50 ± 1.414	15.50 ± 0.707
DO6	—	—	—	—	15.50 ± 0.707	—	—	—	17.50 ± 0.707	—
DO7	—	16.50 ± 0.707	—	—	—	—	—	—	13.50 ± 0.707	—
ACT301	—	—	—	18.50 ± 2.121	—	—	—	—	—	—
ACT302	—	—	—	—	—	17.50 ± 2.12	—	—	19.50 ± 1.414	—
ACT303	—	—	16.50 ± 0.707	—	—	15.0 ± 0.00	—	—	12.50 ± 0.707	—
ACT304	—	16.50 ± 0.707	—	15.50 ± 0.707	—	19.50 ± 1.414	14.50 ± 0.707	—	—	—
ACT307	16 ± 2.828	—	—	13.50 ± 0.707	—	15.50 ± 2.12	—	—	—	—

ST-Salmonella typhi; CA-Candida albicans; EF-Enterococcus faecalis; EC-Escherichia coli; PA-Pseudomonas aeruginosa; KP-Klebsiella pneumonia; SA-Staphylococcus aureus; ST-Streptococcus pyogenes; PM-Proteus mirabilis; VC-Vibrio cholerae.